About this trial
The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.
Eligibility criteria
Qualifiers
In accordance with ICD-11 for Anxiety Disorders;
Between the ages of 18-60;
Completed at least 9 years of education;
Ability to use computers or smartphone;
Disqualifiers
With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
Use of cognitive-enhancing medications within the past 6 months;
With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
Trial design
Treatments tested in this trial
- AI-based rehabilitation treatment combined with standard treatment
- Treatment as Usual (TAU)